Ken Griffin Check Cap LTD Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.06 - $7.2 $2,872 - $344,649	47,868 Added 51.22%	141,319 $41,000
Q2 2022 Aug 15, 2022	SELL	$0.31 - $0.4 $32,901 - $42,453	-106,134 Reduced 53.18%	93,451 $29,000
Q1 2022 May 16, 2022	BUY	$0.37 - $0.69 $66,373 - $123,778	179,389 Added 888.24%	199,585 $78,000
Q4 2021 Feb 14, 2022	SELL	$0.66 - $1.11 $77,982 - $131,153	-118,156 Reduced 85.4%	20,196 $13,000
Q1 2021 May 17, 2021	BUY	$1.15 - $3.07 $159,104 - $424,740	138,352 New	138,352 $244,000
Q4 2020 Feb 16, 2021	SELL	$0.26 - $0.46 $47,309 - $83,702	-181,961 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.32 - $0.8 $58,227 - $145,568	181,961 New	181,961 $66,000
Q2 2019 Aug 14, 2019	SELL	$2.12 - $2.77 $26,569 - $34,716	-12,533 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.9 - $3.9 $23,812 - $48,878	12,533 New	12,533 $0

9.1K

Ticker CHEK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 116,412,000
Market Cap $101M
Description
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for d...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.